Okairos
SwitzerlandEntry
2011
Hold
2yr
Exit
2013
Who owns Okairos?
Okairos is a Swiss Biotech company, now owned by GlaxoSmithKline, which acquired it in 2013 from Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
GlaxoSmithKline
Exit Year
2013
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Okairos?
Okairos is now owned by GlaxoSmithKline, which acquired it in 2013 from Boehringer Ingelheim Venture Fund.
When did GlaxoSmithKline acquire Okairos?
GlaxoSmithKline acquired Okairos in 2013, buying from Boehringer Ingelheim Venture Fund.
Who did Okairos sell to?
Boehringer Ingelheim Venture Fund sold Okairos to GlaxoSmithKline in 2013 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue